Regenerative Patch Technologies
PrivateLast Round
Grant
Jul 27, 2023
Total Funding Raised
$28.71M
Company Overview
Regenerative Patch Technologies operates in Healthcare & Life Sciences and is based in Menlo Park, California. Its latest recorded funding round was a Grant round in July 2023.
Regenerative Patch Technologies is a biotechnology company that develops stem cell-based implant technology for the treatment of retinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regenerative Patch Technologies Comparables
Compare Regenerative Patch Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Luxa Biotechnology | 90% | |
| Opsis Therapeutics | 84% | |
| Eyestem Research | 82% |
For institutional investors. Book with your work email.
Regenerative Patch Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 27, 2023 | ||||
| Strategic | Apr 7, 2017 | ||||
| Grant | Mar 13, 2014 |
For institutional investors. Book with your work email.
Regenerative Patch Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Marcus Foundation | Grant |
| California Institute for Regenerative Medicine | Grant |
| University of Southern California | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors increased 57% MoM.
- Apr 16, 2026
Monthly visitors grew 60% MoM.
For institutional investors. Book with your work email.
Regenerative Patch Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Regenerative Patch Technologies's valuation, stock price, and market status.
Is Regenerative Patch Technologies a public or private company?
Regenerative Patch Technologies is a private company.
What is the current stock price of Regenerative Patch Technologies?
Regenerative Patch Technologies is a private company, so its shares have no public market price. Caplight tracks Regenerative Patch Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Regenerative Patch Technologies worth (valuation)?
Valuation information for Regenerative Patch Technologies is not publicly available.
Can I buy Regenerative Patch Technologies stock?
Regenerative Patch Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Regenerative Patch Technologies's last funding round?
Regenerative Patch Technologies's most recent funding round was Grant on July 27, 2023.
Who are the main investors in Regenerative Patch Technologies?
Key investors in Regenerative Patch Technologies include California Institute for Regenerative Medicine.
Will Regenerative Patch Technologies IPO soon?
No public IPO plans have been announced for Regenerative Patch Technologies.
How can I track Regenerative Patch Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Regenerative Patch Technologies's shares on secondary markets.